✦ LIBER ✦

Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis

✍ Scribed by Jing Ma; Haojie Li; Ed Giovannucci; Lorelei Mucci; Weiliang Qiu; Paul L Nguyen; J Michael Gaziano; Michael Pollak; Meir J Stampfer

Book ID: 117784813
Publisher: The Lancet
Year: 2008
Tongue: English
Weight: 147 KB
Volume: 9
Category: Article
ISSN: 1470-2045
DOI: 10.1016/s1470-2045(08)70235-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term overall survival and metastasi

Long-term overall survival and metastasis-free survival for men with prostate-specific antigen-recurrent prostate cancer after prostatectomy: analysis of the Center for Prostate Disease Research National Database

✍ Emmanuel S. Antonarakis; Yongmei Chen; Sally I. Elsamanoudi; Stephen A. Brassell 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 486 KB

Age, body mass index, and serum prostate

Age, body mass index, and serum prostate-specific antigen correlate with bone loss in men with prostate cancer not receiving androgen deprivation therapy

✍ Francisco A Conde; Linda Sarna; Roberta K Oka; Donna L Vredevoe; Matthew B Retti 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 134 KB

Prognostic value of Her-2/neu and DNA in

Prognostic value of Her-2/neu and DNA index for progression, metastasis and prostate cancer-specific death in men with long-term follow-up after radical prostatectomy

✍ Sumit Isharwal; Michael Craig Miller; Jonathan I. Epstein; Leslie A. Mangold; El 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 French ⚖ 300 KB

## Abstract Abnormal DNA content in tumor cells represents large scale chromosomal alterations and reflects later changes of genetic instability. __Her‐2/neu__ oncogene is amplified in 20–30% of breast and ovarian cancer patients and is associated with poor prognosis. Therefore, we evaluated progno